World News

Weight-Loss Pill Study Compares Effectiveness to Injectables

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

  • Now Playing

    New Study Shows Effectiveness, Side Effects for Weight-Loss Pills

    02:44

  • UP NEXT

    Jenna Bush Hager and Rosie Perez Learn Boxing Basics!

    03:33

  • Doctor Shares Ways to Recognize and Treat Chronic Inflammation

    04:13

  • Doctor Shares What to Know About the 2025 Flu Shot

    04:07

  • Try These Simple and Realistic Ways to Eat Smarter

    04:32

  • Colorectal Cancer Alliance CEO Talks Project Cure Investment

    05:30

  • How New Early Cancer Screening Guidelines Are Saving Lives

    04:19

  • FDA Reviews Claims of Covid Vaccine Link to Child Deaths

    02:12

  • Dietitian Helps Two Friends Tackle Fitness Goals in Their 40s

    07:37

  • Experts Share Lifestyle Tips to Help Lower High Cholesterol

    05:02

  • Queen Latifah Talks Breaking Menopause Taboos, Music Career

    05:58

  • Popular Snacks Get a Revamp in Push to Remove Artificial Dyes

    04:13

  • RFK Jr. Releases Child Health Report Without Clear Policy Change

    02:20

  • Naomi Watts on How Men Can Support Women During Menopause

    04:50

  • How to Recognize Chronic Pain and Find Relief

    04:23

  • Inside America’s Growing Divide on Vaccines

    05:06

  • Doctor Shares Tips to Find Relief Amid 2025 Fall Allergy Season

    02:33

  • RFK Jr., HHS Reportedly Plans to Link Autism to Tylenol Use

    01:43

  • RFK Jr Faces Senate Grilling as Calls for His Resignation Grow

    02:39

  • Montell Jordan Shares ‘Journey’ to Being a 2-Time Cancer Survivor

    05:51

Nearly 12% of Americans have used GLP-1s like Ozempic and Wegovy, which require a weekly injection. A new study from Novo Nordisk offers encouraging news in the race to develop a pill version of the medications. NBC’s medical contributor Dr. Natalie Azar joins TODAY to break down the results of the study, which includes the pill’s effectiveness, side effects and shares when it is expected to become available.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button